Gilead Sciences (GILD) Tops Q2 EPS by 5c, Beats on Revenue; Offers FY25 Guidance
Tweet
Share
E-mail
Get Alerts GILD Hot Sheet
Price: $138.92 +0.40%
Financial Fact:
Income before provision for income taxes: 4.28B
Today's EPS Names:
ELWT, CAAP, RNW, More
Financial Fact:
Income before provision for income taxes: 4.28B
Today's EPS Names:
ELWT, CAAP, RNW, More
Join SI Premium – FREE
Gilead Sciences (NASDAQ: GILD) reported Q2 EPS of $2.01, $0.05 better than the analyst estimate of $1.96. Revenue for the quarter came in at $7.1 billion versus the consensus estimate of $6.97 billion.
GUIDANCE:
Gilead Sciences sees FY2025 EPS of $7.95-$8.25, versus the consensus of $8.00. Gilead Sciences sees FY2025 revenue of $28.3-28.7 billion, versus the consensus of $28.7 billion.
For earnings history and earnings-related data on Gilead Sciences (GILD) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Infleqtion raises Q2 revenue to $13.5M after contract restatement
- Tesla to launch Cybercab in Austin this month - report
- HSBC Upgrades Blue Star Limited (BLSTR:IN) to Buy
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
